Trial Profile

Effect of TP-252 as adjunct therapy to endoscopic surveillance in young familial adenomatous polyposis patients and as adjunct therapy to 5-ASA for maintenance of remission in ulcerative colitis patients.

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 29 May 2018

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

23 May 2018 According to the Thetis Pharmaceuticals media release, this trial is expected to begin 2019.
22 Jan 2016 New trial record
19 Jan 2016 According to Thetis media release, company is planning to initiate this trial in 2017.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com